Investor List:

Top Diagnostics Series B Investors in London (8)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Diagnostics investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Shamik Parekh, Investor at Octopus Ventures
Shamik Parekh
Sweet spot: $4.0M
Range: $1M - $20.0M
Investors in London, Investors in Israel, Investors in Europe, Investors in United Kingdom
Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in Consumer Health (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Consumer Health (Seed), Investors in AI (Seed), Investors in Health IT (Series A), Investors in AI (Seed), Investors in Diverse Investors (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Investors who invested in female founders (Other Lists), Investors in AI (Seed), Investors in AI (Series A), Investors in Israel (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Consumer Health (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Seed), Investors in AI (Series A), Investors in AI (Series A), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Series A), Investors in AI (Series B), Investors in AI (Series B), Investors in Consumer Health (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in Health IT (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in London (Other Lists), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in DeepTech (Seed), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Series B), Investors in DeepTech (Seed), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Shahzad Malik, General Partner at Advent Life Sciences
Shahzad Malik
Advent Life Sciences·General Partner
Sweet spot: $1M
Range: $25K - $5.0M
Investors in London
Photo of Andrew Noyons, Partner at Hambro Perks
Andrew Noyons
Hambro Perks·Partner
Sweet spot: $7.5M
Range: $5.0M - $10.0M
Investors in London
Investors in Medical Devices (Seed), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in FinTech (Series B), Investors in Medical Devices (Seed), Investors in FinTech (Series A), Investors in Medical Devices (Series A), Investors in FinTech (Series B), Investors in Medical Devices (Series B), Investors in London (Other Lists), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Medical Devices (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in FinTech (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in FinTech (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in FinTech (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed)
Photo of Genghis Lloyd-Harris, Partner at Abingworth
Genghis Lloyd-Harris
Abingworth·Partner
Sweet spot: $22.5M
Range: $15.0M - $30.0M
Investors in London
Photo of Alun Williams, Investor at Parkwalk Advisors
Alun Williams
Sweet spot: $1.6M
Range: $1.3M - $2.0M
Investors in London
Investors in AI (Series B), Investors in FinTech (Series B), Investors in AI (Seed), Investors in Health & Hospital Services (Series B), Investors in AI (Seed), Investors in AI (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in AI (Series A), Investors in FinTech (Series A), Investors in Health & Hospital Services (Series A), Investors in AI (Series B), Investors in FinTech (Series B), Investors in Health & Hospital Services (Series B), Investors in London (Other Lists), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in FinTech (Seed), Investors in FinTech (Series A), Investors in Health & Hospital Services (Seed), Investors in FinTech (Seed)
Photo of Neil Cameron, Investor at Parkwalk Advisors
Neil Cameron
Sweet spot: $1.6M
Range: $1.3M - $2.0M
Investors in London
Investors in Advertising (Series B), Investors in Advertising (Series A), Investors in Advertising (Seed), Investors in Retail (Seed), Investors in MarketingTech (Seed), Investors in EnergyTech (Series B), Investors in E-commerce (Series B), Investors in MarketingTech (Series B), Investors in EnergyTech (Series A), Investors in MarketingTech (Series A), Investors in EnergyTech (Seed), Investors in E-commerce (Series A), Investors in Retail (Series A), Investors in Advertising (Seed), Investors in Retail (Series B), Investors in FinTech (Series B), Investors in Health IT (Series A), Investors in SaaS (Series B), Investors in E-commerce (Seed), Investors in EnergyTech (Seed), Investors in E-commerce (Seed), Investors in Health IT (Seed), Investors in MarketingTech (Seed), Investors in Retail (Seed), Investors in SaaS (Seed), Investors in Advertising (Series A), Investors in E-commerce (Series A), Investors in EnergyTech (Series A), Investors in FinTech (Series A), Investors in Health IT (Series A), Investors in MarketingTech (Series A), Investors in Retail (Series A), Investors in SaaS (Series A), Investors in Advertising (Series B), Investors in E-commerce (Series B), Investors in EnergyTech (Series B), Investors in FinTech (Series B), Investors in Health IT (Series B), Investors in MarketingTech (Series B), Investors in SaaS (Series B), Investors in Retail (Series B), Investors in London (Other Lists), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in FinTech (Seed), Investors in SaaS (Series A), Investors in Health IT (Seed), Investors in FinTech (Series A), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in FinTech (Seed), Investors in SaaS (Seed)
Photo of Martin Glen, Investor at Parkwalk Advisors
Martin Glen
Sweet spot: $1.6M
Range: $1.3M - $2.0M
Investors in London
Investors in Pharmaceuticals (Seed), Investors in Chemicals (Series A), Investors in Pharmaceuticals (Series B), Investors in Chemicals (Seed), Investors in Chemicals (Series B), Investors in FinTech (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Chemicals (Seed), Investors in FinTech (Series A), Investors in Chemicals (Series A), Investors in Pharmaceuticals (Series A), Investors in FinTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Chemicals (Series B), Investors in London (Other Lists), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in FinTech (Seed), Investors in FinTech (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in FinTech (Seed)
Photo of Evelyn Bourke, Angel
Evelyn Bourke
Angel
Sweet spot: $25K
Range: $5K - $50K
Investors in London
Investors in Insurance (Seed), Investors in E-commerce (Series B), Investors in Insurance (Series B), Investors in Health & Hospital Services (Series B), Investors in E-commerce (Seed), Investors in E-commerce (Seed), Investors in Health IT (Seed), Investors in Insurance (Seed), Investors in Health & Hospital Services (Seed), Investors in Insurance (Series B), Investors in E-commerce (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in London (Other Lists), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Get new data & insights delivered to your inbox